Search results
High price of popular diabetes drugs deprives low-income people of effective treatment
Daily Montanan via Yahoo News· 5 days agoWithout Ozempic or a similar drug, Cooper Harris suffers blackouts, becomes too tired to watch her...
CNBC's Inside India newsletter: IPO boom looks to break new records
CNBC· 8 hours agoThis report is from this week's CNBC's "Inside India" newsletter which brings you timely, insightful...
Nayzilam and cost: Reducing long-term drug costs and more
Medical News Today· 7 days agoNayzilam (midazolam) is a brand-name nasal spray that’s prescribed for a type of seizure that occurs...
Innovations in Workers’ Compensation: A Conversation with Joseph Berardo Jr. of Carisk Partners
Risk & Insurance· 6 days agoRisk & Insurance: What changes have you observed in the management of catastrophic and complex...
Auvelity and cost: Reducing long-term drug costs and more
Medical News Today· 7 days agoThe cost of the drug, with and without insurance, can depend on several factors. To save money on...
What a Trump Presidency Could Mean for the Middle Class
GOBankingRates via Yahoo Finance· 6 days agoOne thing that just about every presidential candidate from both parties and all corners of the...
Cost and Dilantin: Financial assistance options, savings, more
Medical News Today· 7 days agoDilantin (phenytoin sodium) is a brand-name drug prescribed to treat or prevent certain types of...
Sorting Through the Details of Healthcare Reform
New Jersey Business Magazine· 3 days agoThe Republican healthcare reform bill that was pulled without a vote in the House of Representatives back in March, shows how hard it will be to repeal...
Mektovi and cost: Reducing long-term drug costs and more
Medical News Today· 7 days agoThe cost of the drug, with and without insurance, can depend on several factors, such as whether...
How Biden and Trump disagree over how to address the cost of health care
KTEP 88.5 El Paso· 7 days agoNPR's Selena Simmons-Duffin is here to talk to us about all things health policy and the elections. SELENA SIMMONS-DUFFIN, BYLINE: I want to zero in on something I find really fascinating that ...